• 1
    Bolli R, Jneid H, Dawn B. Bone marrow cell-mediated cardiac regeneration a veritable revolution. J Am Coll Cardiol 2005; 46:16591661.
  • 2
    Abdel-latif A, Bolli R, Tleyjeh IM et al. Adult bone marrow-derived cells for cardiac repair: A systematic review and meta-analysis. Arch Int Med 2007; 167:989997.
  • 3
    Min JY, Yang Y, Converso KL et al. Transplantation of embryonic stem cells improves cardiac function in postinfarcted rats. J Appl Physiol 2002; 92:288296.
  • 4
    Kofidis T, de Bruin JL, Yamane T et al. Insulin-like growth factor promotes engraftment, differentiation, and functional improvement after transfer of embryonic stem cells for myocardial restoration. Stem Cells 2004; 22:12391245.
  • 5
    Leor J, Gerecht S, Cohen S et al. Human embryonic stem cell transplantation to repair the infarcted myocardium. Heart 2007; 93:12781284.
  • 6
    Swijnenburg RJ, Tanaka M, Vogel H et al. Embryonic stem cell immunogenicity increases upon differentiation after transplantation into ischemic myocardium. Circulation 2005; 112:I166I172.
  • 7
    Nussbaum J, Minami E, Laflamme MA et al. Transplantation of undifferentiated murine embryonic stem cells in the heart: Teratoma formation and immune response. FASEB J 2007; 21:13451357.
  • 8
    Ratajczak MZ, Kucia M, Reca R et al. Stem cell plasticity revisited: CXCR4-positive cells expressing mRNA for early muscle, liver and neural cells ‘hide out’ in the bone marrow. Leukemia 2004; 18:2940.
  • 9
    Kucia M, Dawn B, Hunt G et al. Cells expressing early cardiac markers reside in the bone marrow and are mobilized into the peripheral blood following myocardial infarction. Circ Res 2004; 95:11911199.
  • 10
    Kucia M, Reca R, Campbell FR et al. A population of very small embryonic-like (VSEL) CXCR4(+)SSEA-1(+)Oct-4+ stem cells identified in adult bone marrow. Leukemia 2006; 20:857869.
  • 11
    Guo Y, Wu WJ, Qiu Y et al. Demonstration of an early and a late phase of ischemic preconditioning in mice. Am J Physiol 1998; 275:H1375H1387.
  • 12
    Guo Y, Jones WK, Xuan YT et al. The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene. Proc Natl Acad Sci U S A 1999; 96:1150711512.
  • 13
    Dawn B, Guo Y, Rezazadeh A et al. Postinfarct cytokine therapy regenerates cardiac tissue and improves left ventricular function. Circ Res 2006; 98:10981105.
  • 14
    Li Q, Li B, Wang X et al. Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy. J Clin Invest 1997; 100:19911999.
  • 15
    Anversa P, Olivetti G. In: PageE, FozzardHA, SolaroRJ, eds. The Heart. The cardiovascular system. 1st ed. New York: Oxford University Press, 2002:75144.
  • 16
    Anversa P, Melissari M, Beghi C et al. Structural compensatory mechanisms in rat heart in early spontaneous hypertension. Am J Physiol 1984; 246:H739H746.
  • 17
    Anversa P, Beghi C, Kikkawa Y et al. Myocardial infarction in rats. Infarct size, myocyte hypertrophy, and capillary growth. Circ Res 1986; 58:2637.
  • 18
    Dawn B, Stein AB, Urbanek K et al. Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function. Proc Natl Acad Sci U S A 2005; 102:37663771.
  • 19
    Orlic D, Kajstura J, Chimenti S et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001; 410:701705.
  • 20
    Wallenstein S, Zucker CL, Fleiss JL. Some statistical methods useful in circulation research. Circ Res 1980; 47:19.
  • 21
    Dawn B, Bolli R. Adult bone marrow-derived cells: Regenerative potential, plasticity, and tissue commitment. Basic Res Cardiol 2005; 100:494503.
  • 22
    Kucia M, Ratajczak J, Ratajczak MZ. Are bone marrow stem cells plastic or heterogenous–that is the question. Exp Hematol 2005; 33:613623.
  • 23
    Strauer BE, Brehm M, Zeus T et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002; 106:19131918.
  • 24
    Schächinger V, Erbs S, Elsasser A et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 2006; 355:12101221.
  • 25
    Toma C, Pittenger MF, Cahill KS et al. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 2002; 105:9398.
  • 26
    Yoon YS, Wecker A, Heyd L et al. Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. J Clin Invest 2005; 115:326338.
  • 27
    Kajstura J, Rota M, Whang B et al. Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion. Circ Res 2005; 96:127137.
  • 28
    Wang Y, Haider HK, Ahmad N et al. Combining pharmacological mobilization with intramyocardial delivery of bone marrow cells over-expressing VEGF is more effective for cardiac repair. J Mol Cell Cardiol 2006; 40:736745.
  • 29
    Meluzin J, Mayer J, Groch L et al. Autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction: The effect of the dose of transplanted cells on myocardial function. Am Heart J 2006;152:975.e9e15.
  • 30
    Schuster MD, Kocher AA, Seki T et al. Myocardial neovascularization by bone marrow angioblasts results in cardiomyocyte regeneration. Am J Physiol Heart Circ Physiol 2004; 287:H525H532.
  • 31
    Iwasaki H, Kawamoto A, Ishikawa M et al. Dose-dependent contribution of CD34-positive cell transplantation to concurrent vasculogenesis and cardiomyogenesis for functional regenerative recovery after myocardial infarction. Circulation 2006; 113:13111325.
  • 32
    Kawamoto A, Iwasaki H, Kusano K et al. CD34-positive cells exhibit increased potency and safety for therapeutic neovascularization after myocardial infarction compared with total mononuclear cells. Circulation 2006; 114:21632169.
  • 33
    Beltrami AP, Barlucchi L, Torella D et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003; 114:763776.
  • 34
    Urbanek K, Rota M, Cascapera S et al. Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival. Circ Res 2005; 97:663673.
  • 35
    Perin EC, Dohmann HF, Borojevic R et al. Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy. Circulation 2004; 110:II213II218.